Use of tolvaptan, a new V2 receptor antagonist, in the treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer (SCLC) - a case series

被引：1
|
作者：
Fraser, I. M. [1 ]
Brooke, A. M. [2 ]
Dorey, N. E. [1 ]
Toy, E. W. [1 ]
机构：
[1] Royal Devon & Exeter NHS Fdn Trust, Dept Oncol, Exeter, Devon, England
[2] Royal Devon & Exeter NHS Fdn Trust, Dept Endocrinol & Diabet, Exeter, Devon, England
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70187-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
186
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 40 条
  • [1] Syndrome of inappropriate antidiuretic hormone secretion and treatment with tolvaptan - a case series
    Vere, J.
    Jude, E.
    LUNG CANCER, 2013, 79 : S47 - S47
  • [2] Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancer
    Tai, Patricia
    Yu, Edward
    Jones, Kurian
    Sadikov, Evgeny
    Mahmood, Shazia
    Tonita, Jon
    LUNG CANCER, 2006, 53 (02) : 211 - 215
  • [3] THE SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC-HORMONE (SIADH) IN SMALL-CELL LUNG-CANCER
    LIST, AF
    HAINSWORTH, JD
    DAVIS, BW
    HANDE, KR
    GRECO, FA
    JOHNSON, DH
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) : 1191 - 1198
  • [4] Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer
    Irem Bilgetekin
    Ismail Erturk
    Fatma Bugdayci Basal
    Cengiz Karacin
    Nuri Karadurmus
    Berna Oksuzoglu
    Umut Demirci
    International Urology and Nephrology, 2021, 53 : 301 - 307
  • [5] Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer
    Bilgetekin, Irem
    Erturk, Ismail
    Basal, Fatma Bugdayci
    Karacin, Cengiz
    Karadurmus, Nuri
    Oksuzoglu, Berna
    Demirci, Umut
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (02) : 301 - 307
  • [6] Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion
    Masayuki Tanemoto
    International Urology and Nephrology, 2024, 56 : 361 - 362
  • [7] Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion
    Tanemoto, Masayuki
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (01) : 361 - 362
  • [8] Syndrome of inappropriate antidiuretic hormone (SIADH) in patients with small cell lung cancer & incidence and response to treatment
    Jellett, L.
    O'Hare, J.
    McAleese, J.
    LUNG CANCER, 2011, 71 : S41 - S41
  • [9] Syndrome of inappropriate antidiuretic hormone (SIADH) in patients with limited stage small cell lung cancer
    Tai, P
    Yu, E
    Skarsgard, D
    Tonita, J
    Jones, K
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S43 - S43
  • [10] A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
    Wada, Koh-ichi
    Matsuyawa, Utane
    Fujimori, Akira
    Arai, Yukinori
    Sudoh, Katsumi
    Sasamata, Masao
    Miyata, Keiji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (01) : 91 - 95
1234